Search

Search Constraints

You searched for: Issue Volume 178(2022)

Search Results

82. Cabergoline, a long-acting dopamine agonist, attenuates L-dopa-induced dyskinesia without L-dopa sparing in a rat model of Parkinson's disease. (May 2022)